NIVF (NewGenIvf Group Limited) Stock Financials & Earnings | Market Cap Arena

NIVFNewGenIvf Group Limited

Mkt Cap$13980

Healthcare·Medical - Healthcare Plans· Thailand·NASDAQ

Revenue (TTM)$6M

Net Income (TTM)$16M

EPS (TTM)$282.52

Free Cash Flow (TTM)-$7M

Gross Margin23.8%

Op. Margin-83.8%

Net Margin283.7%

FCF Margin-121.4%

P/S Ratio (TTM)0.0x

P/E Ratio (TTM)0.0x

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q3 21	$0	$0	-$80
Q1 22	$0	$0	-$160K
Q2 22	$0	$0	-$123K
Q3 22	$0	$0	-$107K
Q4 22	$0	$0	-$116K
Q1 23	$0	$0	-$511K
Q2 23	$0	$0	-$367K
Q3 23	$0	$0	-$378K
Q4 23	$2M	$197K	-$1M
Q3 24	$1M	$646K	$216K
Q4 24	$1M	$359K	-$1M
Q3 25	$1M	$118K	-$3M

Valuation

Quarter	P/S	P/E
Q3 21	—	—
Q1 22	—	—
Q2 22	—	—
Q3 22	—	0.5x
Q4 22	—	0.0x
Q1 23	—	0.0x
Q2 23	—	0.0x
Q3 23	—	0.0x
Q4 23	0.0x	—
Q3 24	0.0x	—
Q4 24	0.0x	—
Q3 25	0.0x	0.0x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 22	-$23K	-$23K
Q4 22	-$35K	-$35K
Q3 23	-$203K	-$203K
Q4 23	-$143K	-$143K
Q4 24	-$6M	-$6M

Capital Expenditures

CapEx

Quarter	CapEx
Q3 22	$0
Q4 22	$0
Q3 23	$0
Q4 23	$4
Q4 24	$3K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 22	—	+5201.0%
Q4 22	—	+144447.5%
Q1 23	—	+219.0%
Q2 23	—	+199.1%
Q3 23	—	+254.5%
Q4 23	—	+2308.8%
Q3 24	—	+146.1%
Q4 24	—	+543.9%
Q3 25	—	+904.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 22	$0	—
Q4 22	$0	—
Q3 23	$0	—
Q4 23	$0	0.0%
Q4 24	$0	0.0%

OpEx Breakdown

Quarter	G&A	S&M	SG&A
Q3 21	—	—	$80
Q1 22	—	—	$160K
Q2 22	—	—	$123K
Q3 22	—	—	$107K
Q4 22	—	—	$116K
Q1 23	—	—	$511K
Q2 23	—	—	$367K
Q3 23	—	—	$378K
Q4 23	—	—	$1M
Q3 24	—	—	$430K
Q4 24	—	—	$1M
Q3 25	$2M	$187K	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 21	$0	$0	$0
Q3 21	$0	$0	$0
Q4 22	$55K	$0	$55K
Q2 23	$122K	$38M	$39M
Q3 23	$39K	$39M	$39M
Q4 23	$54K	$0	$54K
Q3 24	$170K	$0	$170K
Q4 24	$458K	$0	$458K
Q3 25	$295K	$0	$295K

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q3 21	51K	+0.0%
Q1 22	51K	+0.0%
Q2 22	51K	+0.0%
Q3 22	51K	+0.0%
Q4 22	51K	+0.0%
Q1 23	51K	+0.0%
Q2 23	51K	+0.0%
Q3 23	51K	+0.0%
Q4 23	51K	+0.0%
Q3 24	51K	+0.0%
Q4 24	114K	+124.4%
Q3 25	114K	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 21	—	—
FY 22	—	—
FY 23	$73K	70
FY 24	$71K	76

NIVF (NewGenIvf Group Limited) Stock Financials & Earnings | Market Cap Arena